期刊文献+

HER-2、贫血和前白蛋白与胃癌预后的关系 被引量:5

Relationship between HER-2,Anemia,Prealbumin and Prognosis of Gastric Cancer
下载PDF
导出
摘要 目的 研究HER-2、术前贫血和前白蛋白水平与胃癌预后的关系。方法 对2008年1月—2009年12月经手术病理确诊、有完整随访资料的103例Ⅲ~Ⅳ期胃癌患者进行回顾性分析。选择性别、年龄、组织学类型、肿瘤部位、肿瘤大小、浸润深度、临床分期、HER-2、术前血红蛋白和血清前白蛋白水平作为观察指标。采用Kaplan-Meier生存分析、Log rank 检验和Cox 比例风险模型进行单因素和多因素分析;组间变量采用χ2检验或Fisher's精确检验。结果 单因素分析显示N分期、HER-2、贫血、临床分期、前白蛋白水平均与胃癌的预后显著相关(P〈0.05);年龄、性别、肿瘤大小和部位与胃癌生存无相关性。Cox多因素分析显示HER-2过表达、贫血、白蛋白水平和临床分期是影响胃癌预后的独立因素(P〈0.05)。结论 (1)临床分期、HER-2、贫血和前白蛋白是胃癌的独立预后因素; (2)淋巴结转移与胃癌预后相关,但不是独立预后因素。(3)贫血的构成比与HER-2状态及临床分期有关,与前白蛋白无关。 Objective To investigate the relationship between HER-2, anemia , prealbumin and the prognosis of gastric cancer.Methods One hundred and three patients diagnosed as primary gastric cancer and staged at Ⅲ-Ⅳ from 2008 to 2009 were retrospectively analyzed. The clinical characteristics such as age, gender, histological type, tumor location, tumor size, infiltration depth, lymph node metastasis, clinical stage, the expression of HER-2, anemia and prealbumin concentration were observed. Survival curves were drawn with the Kaplan-Meier analysis. Comparisons were made with the Log rank test. Cox proportion risk model was established and χ2-test or Fisher's exact probability test was used to compare clinical characteristics. Results Lymph node metastasis, clinical stage, the expression of HER-2, anemia and prealbumin were identified as influencing factors about the prognosis of gastric cancer, while age, gender, histological type, tumor location and size were irrelevant with the survival of tumor patients. Multiple logistic regression analysis showed that independent and significant factors associated with the prognosis of gastric cancer were clinical stage, the expression level of HER-2, anemia and prealbumin concentration(P〈0.05). Conclusion (1)HER-2 over-expression, anemia and low prealbumin cocentration are the independent and significant factors on the prognosis of gastric cancer. (2)Lymph node metastasis is the influencing but not the independent factor on the prognosis of gastric cancer.(3)There is a significant difference on the proportion of anemia between HER-2 positive group and negative group, and the same result is found in stage Ⅲ group and stage Ⅳ group but not in prealbumin groups.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2013年第5期439-443,共5页 Cancer Research on Prevention and Treatment
关键词 胃癌 预后 HER-2 贫血 前白蛋白 Gastric cancer Prognosis HER-2 Anemia Prealbumin
  • 相关文献

参考文献6

二级参考文献39

共引文献421

同被引文献44

  • 1ShuiWang Yong-BinDing Guo-YuChen Jian-GuoXia Zhen-YanWu.Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma[J].World Journal of Gastroenterology,2004,10(12):1815-1818. 被引量:32
  • 2Ling Yang.Incidence and mortality of gastric cancer in China[J].World Journal of Gastroenterology,2006,12(1):17-20. 被引量:345
  • 3胡青钢,刘小卫,郑启昌.酪氨酸激酶Syk在肝癌中的表达及与血管生成的关系[J].中华肝胆外科杂志,2007,13(7):463-465. 被引量:10
  • 4Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2) :69-90.
  • 5He J, Chen WQ. Chinese Cancer Registry Annual Report 2012 [M]. Beijing:Press of Military Medical Sciences, 2012.
  • 6McGhan LJ, Pockaj BA, Gray RJ,et al. Validation of the upda- ted 7th edition AJCC TNM staging criteria for gastric adenocar- cinoma[J]. J Gastrointest Surg,2012, 16(1):53-61.
  • 7Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophag- eal junction cancer (TOGA) .a phase 3, open-label, randomized controlled trial[J]. Lancet,2010, 376(9742) :687-697.
  • 8Park SH, Lee J, Lee SH, et al. Anemia is the strongest prog- nostic factor for outcomes of 5-fluorouracil-based first-line chem- otherapy in patients with advanced gastric cancer[J]. Cancer Chemother Pharmacol, 2006, 57 (1) : 91-96.
  • 9Lee J, Lim T, Uhm JE, et al. Prognostic model to predict sur- vival following first-line chemotherapy in patients with metastat- ic gastric adenocarcinoma[J]. Ann Oncol, 2007, 18 (5): 886- 891.
  • 10Catalano V, Graziano F, Santini D, et al. Second-line chemo- therapy for patients with advanced gastric cancer:who may bene- fit? [J]. Br J Cancer,2008, 99(9) :1402-1407.

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部